Sequential adjuvant therapy: The Memorial Sloan-Kettering Cancer Center experience

Seminars in Oncology

Volumn 23, Issue 1 SUPPL. 1, 1996, Pages 58-64

  Hudis, C ^a   Seidman, A ^a   Raptis, G ^a   Fennelly, D ^a   Gilewski, T ^a   Baselga, J ^a   Theodoulou, M ^a   Sklarin, N ^a   Moynahan, M ^a   Surbone, A ^a   Currie, V ^a   Lebwohl, D ^a   Uhlenhopp, M ^a   Crown, J ^a   Norton, L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CROSS RESISTANCE; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFECT; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CANCER CARE FACILITIES; CELL DIVISION; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; NEW YORK CITY; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS;

EID: 0029873269     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)